Amphotericin B Cystetic for Inhalation (ABCI)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Amphotericin B Cystetic for Inhalation (ABCI), covering 2025-02-12 to 2025-02-12. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People with Cystic Fibrosis [Phase 1]